Medtronic has been making significant strides in its Cranial & Spinal Technologies (CST) business unit recently.
Medtronic has received Food and Drug Administration clearance for a next-generation spine surgery system that combines artificial intelligence-based planning, real-time navigation and robotic ...
GALWAY, Ireland - Medtronic (NYSE:MDT) announced today it has received U.S. Food and Drug Administration clearance for its Stealth AXiS surgical system, an integrated platform combining planning, ...
GALWAY, Ireland, Feb. 13, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS ...
The U.S. Food and Drug Administration classified a software glitch with Medtronic's StealthStation S8 surgical navigation system as a Class I recall, the most serious issued by the agency.
The Stealth AXiSTM system is cleared for spine procedures in the United States, with an underlying architecture designed to support future cranial and ENT applications, pending 510(k) clearance. Built ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results